CARM1 and cancer: Thus, we found that circHMGB2 induces the formation of an immunosuppressive TME via the miR-181a-5p/CARM1 axis, which inhibits the type 1 IFN response in cancer cells and enhances cancer cell resistance to the cytotoxic effects of T cells.